The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study

Transfusion

Volumn 37, Issue 7, 1997, Pages 719-726

  Silliman, C C ^a,b   Paterson, A J ^b   Dickey, W O ^b   Stroncek, D F ^c,d,e   Popovsky, M A ^c   Caldwell, S A ^c   Ambruso, D R ^c  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b Bonfils Blood Center   (United States)

^c Dept of Lab Medicine and Pathology ^*

^d UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^e AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; CLINICAL ARTICLE; FEMALE; HLA SYSTEM; HUMAN; LEUKOCYTE ACTIVATION; LIPID BLOOD LEVEL; LUNG INJURY; MALE; PATHOGENESIS;

EID: 0030790354     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37797369448.x     Document Type: Article

References (25)

1. Popovsky MA, Moore SB. Diagnostic and pathogenetic consid-erations in transfusion-related acute lung injury. Transfusion 1985;25:573-7.
2. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992;32:589-92.
3. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury (letter). Transfusion 1993;33:444-5.
4. Carilli AD, Ramanamurty MV, Chang YS, et al. Noncardiogenic pulmonary edema following blood transfusion. Chest 1978;74:310-2.
5. Yomtovian R, Wine W, Press C, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophilspecific antibody. Lancet 1984;1:244-6.
6. Van Buren NL, Stroncek DF, Clay ME, et al. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990;30:42-5.
7. Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. Vox Sang 1992;63:133-6.
8. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994;124:684-94.
9. Silliman CC, Dickey WO, Paterson AJ, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 1996;36:133-9.
10. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest 1990;85:1135-43.
11. Rabinovici R, Esser KM, Lysko PG, et al. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res 1991;69:12-25.
12. Zmijewski C. Detection and identification of HLA antibodies. In: Zachery A, Terevi G, eds. American Society of Histocompatibility and Immunogenetics Laboratory Manual. 2nd ed. Kansas City: ASHI 1990:249-59.
13. Stroncek DF, Vercellotti GM, Hammerschmidt DE, et al. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis. Blood 1992;80:241-8.
14. Ambruso DR, Bentwood B, Henson PM, Johnston RB Jr. Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules. Pediatr Res 1984;18:1148-53.
15. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. J Pharmacol Exp Ther 1990;255:962-8.
16. Vercellotti GM, Yin HQ, Gustafson KL, et al. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 1988;71:1100-7.
17. Kollef MH, Schuster DP. The adult respiratory distress syndrome. N Engl J Med 1995;332:27-37.
18. Silliman CC, Allard J, Voelkel NF, et al. Plasma and lipids from stored blood cause acute lung injury in an animal model (abstract). J Invest Med 1996;44:255a.
19. Boshkov L, Silliman C, Clarke G, et al. Transfusion related acute lung injury (TRALI) following platelet transfusion: a study of possible etiologic factors (abstract). Blood 1995;86(Suppl):354a.
20. Sauaia A, Moore FA, Moore EE, et al. Early predictors of postinjury multiple organ failure. Arch Surg 1994;129:39-45.
21. Heddle NM, Klama L, Singer J, et al. The role of plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
22. Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994;34:20-5.
23. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23.
24. Cohen AB, MacArthur C, Idell S, et al. A peptide from alveolar macrophages that releases neutrophil enzymes into the lung in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1988;137:1151-8.
25. Muylle L, Wouters E, De Bock R, Peetermans ME. Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transfus Med 1992;2:289-93.